Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial

Key Points

• This research aims to compare the continuous glucose monitoring profiles of different glucose-lowering medications in diabetes management.
• Analyzed CGM metrics across four glucose-lowering medications
• Evaluated %CV (coefficient of variation) for each medication
• Assessed achievement of CGM-based glycemic targets
• Incretin drugs exhibited the lowest %CV among the medications
• Incretin usage resulted in the least occurrences of hypoglycemia
• Best achievement of CGM-based glycemic targets was noted with incretin class drugs